Wave Life Sciences Ltd

General ticker "WVE" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $1.9B

Wave Life Sciences Ltd follows the US Stock Market performance with the rate: 51.0%.

Estimated limits based on current volatility of 3.8%: low 12.82$, high 13.82$

Factors to consider:

  • Current price 82.5% above estimated high
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.35$, 7.19$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.22$, 7.06$]

Financial Metrics affecting the WVE estimates:

  • Negative: Non-GAAP EPS, $ of -0.55 <= 0.10
  • Negative: Operating profit margin, % of -37.50 <= 1.03
  • Negative: Operating cash flow per share per price, % of -3.50 <= 2.35
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term WVE quotes

Long-term WVE plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $40.96MM $3.65MM $113.31MM
Operating Expenses $167.98MM $166.37MM $181.30MM
Operating Income $-127.02MM $-162.72MM $-68.00MM
Non-Operating Income $4.57MM $1.58MM $9.81MM
R&D Expense $121.88MM $115.86MM $130.01MM
Income(Loss) $-122.45MM $-161.14MM $-58.19MM
Taxes $-0.20MM $0.68MM $-0.68MM
Profit(Loss) $-122.25MM $-161.82MM $-57.51MM
Stockholders Equity $32.50MM $-45.09MM $39.63MM
Assets $207.01MM $146.39MM $274.95MM
Operating Cash Flow $-88.99MM $-127.78MM $-19.43MM
Capital expenditure $0.56MM $1.36MM $1.11MM
Investing Cash Flow $-0.56MM $-1.25MM $-1.11MM
Financing Cash Flow $55.83MM $67.19MM $132.53MM
Earnings Per Share* $-2.36 $-2.05 $-0.54

* EPS are Split Adjusted, recent splits may be reflected with a delay.